| Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer H Abdollahi, B Mofid, I Shiri, A Razzaghdoust, A Saadipoor, A Mahdavi, ... La radiologia medica 124 (6), 555-567, 2019 | 135 | 2019 |
| CT imaging markers to improve radiation toxicity prediction in prostate cancer radiotherapy by stacking regression algorithm S Mostafaei, H Abdollahi, S Kazempour Dehkordi, I Shiri, A Razzaghdoust, ... La radiologia medica 125 (1), 87-97, 2020 | 84 | 2020 |
| Randomized, double‐blind, placebo‐controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy A Saadipoor, A Razzaghdoust, N Simforoosh, A Mahdavi, ... Phytotherapy research 33 (2), 370-378, 2019 | 80 | 2019 |
| Rectal wall MRI radiomics in prostate cancer patients: prediction of and correlation with early rectal toxicity H Abdollahi, SR Mahdavi, B Mofid, M Bakhshandeh, A Razzaghdoust, ... International journal of radiation biology 94 (9), 829-837, 2018 | 58 | 2018 |
| MRI radiomic analysis of IMRT-induced bladder wall changes in prostate cancer patients: a relationship with radiation dose and toxicity H Abdollahi, K Tanha, B Mofid, A Razzaghdoust, A Saadipoor, L Khalafi, ... Journal of Medical Imaging and Radiation Sciences 50 (2), 252-260, 2019 | 47 | 2019 |
| Randomized, double-blind pilot study of nanocurcumin in bladder cancer patients receiving induction chemotherapy S Sandoughdaran, A Razzaghdoust, A Tabibi, A Basiri, N Simforoosh, ... Urology Journal, 2020 | 35 | 2020 |
| Predictors of chemotherapy-induced severe anemia in cancer patients receiving chemotherapy A Razzaghdoust, B Mofid, P Peyghambarlou Supportive Care in Cancer 28 (1), 155-161, 2020 | 33 | 2020 |
| Famotidine as a radioprotector for rectal mucosa in prostate cancer patients treated with radiotherapy: phase I/II randomized placebo-controlled trial A Razzaghdoust, H Mozdarani, B Mofid Strahlentherapie und Onkologie 190 (8), 739-744, 2014 | 29 | 2014 |
| Development of a simplified multivariable model to predict neutropenic complications in cancer patients undergoing chemotherapy A Razzaghdoust, B Mofid, M Moghadam Supportive Care in Cancer 26 (11), 3691-3699, 2018 | 26 | 2018 |
| Association of immunohistochemical markers of tumor subtype with response to neoadjuvant chemotherapy and survival in patients with muscle-invasive bladder cancer A Razzaghdoust, M Ghajari, A Basiri, PM Torbati, A Jafari, MR Fattahi, ... Investigative and clinical urology 62 (3), 274, 2021 | 23 | 2021 |
| Reduction in radiation‐induced lymphocytopenia by famotidine in patients undergoing radiotherapy for prostate cancer A Razzaghdoust, H Mozdarani, B Mofid, SMR Aghamiri, AH Heidari The Prostate 74 (1), 41-47, 2014 | 23 | 2014 |
| Predicting chemotherapy-induced thrombocytopenia in cancer patients with solid tumors or lymphoma A Razzaghdoust, B Mofid, M Zangeneh Journal of Oncology Pharmacy Practice 26 (3), 587-594, 2020 | 21 | 2020 |
| Radioprotective effects of sulfur-containing mineral water of ramsar hot spring with high natural background radiation on mouse bone marrow cells AH Heidari, AS Monfared, H Mozdarani, A Mahmoudzadeh, ... Journal of Biomedical Physics & Engineering 7 (4), 347, 2017 | 13 | 2017 |
| Data‐Driven Discovery of Molecular Targets for Antibody‐Drug Conjugates in Cancer Treatment A Razzaghdoust, S Rahmatizadeh, B Mofid, S Muhammadnejad, ... BioMed research international 2021 (1), 2670573, 2021 | 12 | 2021 |
| Clinical outcome and prognostic factors for very young patients with breast cancer: A comparative matched single institution study in Iran. A Rakhsha, A Anvari, A Razzaghdoust, ASY Kashi International Journal of Cancer Management 10 (9), 2017 | 11 | 2017 |
| A Comparative Study of Treatment Toxicities Between FOLFOX 4 and Modified FOLFOX 6 in Iranian Colorectal Cancer Patients. ASY Kashi, A Razzaghdoust, A Rakhsha Iranian Journal of Cancer Prevention 10 (1), 2017 | 11 | 2017 |
| Nanocurcumin as a radioprotective agent against radiationinduced mortality in mice. R Sadeghi, A Razzaghdoust, M Bakhshandeh, F Nasirinezhad, B Mofid Nanomedicine Journal 6 (1), 2019 | 10 | 2019 |
| Identifying predictive factors for severe anemia in cancer patients treated with cytotoxic chemotherapy B Mofid, A Razzaghdoust, P Peyghambarlou Annals of oncology 29, ix133, 2018 | 6 | 2018 |
| A comparative study of cisplatin-based definitive chemo-radiation in non-metastatic squamous cell carcinoma of the esophagus B Mofid, A Razzaghdoust, ASY Kashi, HR Mirzaei Electronic physician 8 (10), 3069, 2016 | 6 | 2016 |
| Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis. B Mofid, A Razzaghdoust, M Ghajari, A Basiri, MR Fattahi, M Houshyari, ... Urology Journal 19 (5), 2022 | 5 | 2022 |
Bahram MofidShahid Beheshti University of Medical SciencesVerified email at sbmu.ac.ir
